A carregar...

EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs

Background: Controversy exists regarding whether EGFR-targeted therapy combined with GEMOX (gemcitabine and oxaliplatin) provides additional benefits over GEMOX alone for biliary tract cancer patients. Therefore, this meta-analysis of randomized controlled trials (RCTs) was performed to assess the e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Cai, Wen, Yuan, Ying, Ge, Weiting, Fan, Yu, Liu, Xue, Wu, Dehao, Hu, Hanguang
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5929093/
https://ncbi.nlm.nih.gov/pubmed/29721058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.23290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!